Related Experiment Video
Updated: May 25, 2026

10:54
Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry
Published on: February 4, 2017
99mTc(I) scorpionate complexes for brain imaging: synthesis, characterization and biological evaluation
Carolina Moura1, Lurdes Gano, Isabel C Santos
1Unidade de Ciências Químicas e Radiofarmacêuticas, Instituto Tecnológico e Nuclear Estrada Nacional 10, 2686-953 Sacavém, Portugal.
Current Radiopharmaceuticals
|January 28, 2012
Summary
Researchers synthesized a novel dihydrobis(azolyl)borate ligand and its technetium-99m complex. This complex shows high stability and brain penetration, making it a promising candidate for brain imaging radiopharmaceuticals.
Area of Science:
- Inorganic Chemistry
- Radiochemistry
- Medicinal Chemistry
Background:
- Dihydrobis(azolyl)borate ligands offer unique coordination properties.
- The fac-[99mTc(CO)3]+ core is a crucial component in developing diagnostic radiotracers.
Purpose of the Study:
- To synthesize and characterize a novel dihydrobis(azolyl)borate ligand and its technetium-99m complex.
- To evaluate the stability and potential of the new complex for brain imaging applications.
Main Methods:
- Synthesis of Na[H2B(tim(Me))(3,5-Me2pz)] (L1) and fac-[99mTc(κ(3)-H(μ-H)B(tim(Me))(3,5-Me2-pz))(CO)3] (4a).
- Characterization using analytical techniques including X-ray diffraction.
- In vitro stability studies in phosphate-buffered saline (PBS).
- In vivo biodistribution studies in mice.
Main Results:
- Successful synthesis of the novel ligand L1 and its rhenium (4) and technetium-99m (4a) complexes.
- Complex 4a demonstrated high radiochemical purity and stability in vitro.
- The B-H...99mTc bond remained intact under physiological conditions.
- Biodistribution studies confirmed blood-brain barrier penetration of complex 4a.
Conclusions:
- Dihydrobis(azolyl)borate ligands can stabilize the fac-[99mTc(CO)3]+ unit.
- Complex 4a exhibits excellent in vitro stability and crosses the blood-brain barrier.
- This compound represents a promising new platform for developing radiopharmaceuticals for brain imaging.
Related Concept Videos
Brain Imaging
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
![Technical Aspect of the Automated Synthesis and Real-Time Kinetic Evaluation of [11C]SNAP-7941](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F59557.jpg&w=3840&q=50)
